Potent costimulation of human CD8 T cells by anti-4-1BB and anti-CD28 on synthetic artificial antigen presenting cells. 2008

Despina Rudolf, and Tobias Silberzahn, and Steffen Walter, and Dominik Maurer, and Johanna Engelhard, and Dorothee Wernet, and Hans-Jörg Bühring, and Gundram Jung, and Byoung S Kwon, and Hans-Georg Rammensee, and Stefan Stevanović
Department of Immunology, Institute for Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076 Tübingen, Germany.

The in vitro generation of cytotoxic T lymphocytes (CTLs) for anticancer immunotherapy is a promising approach to take patient-specific therapy from the bench to the bedside. Two criteria must be met by protocols for the expansion of CTLs: high yield of functional cells and suitability for good manufacturing practice (GMP). The antigen presenting cells (APCs) used to expand the CTLs are the key to achieving both targets but they pose a challenge: Unspecific stimulation is not feasible because only memory T cells are expanded and not rare naïve CTL precursors; in addition, antigen-specific stimulation by cell-based APCs is cumbersome and problematic in a clinical setting. However, synthetic artificial APCs which can be loaded reproducibly with MHC-peptide monomers and antibodies specific for costimulatory molecules could resolve these problems. The purpose of this study was to investigate the potential of complex synthetic artificial APCs in triggering the costimulatory molecules CD28 and 4-1BB on the T cell. Anti-4-1BB antibodies were added to an established system of microbeads coated with MHC-peptide monomers and anti-CD28. Triggering via CD28 and 4-1BB resulted in strong costimulatory synergy. The quantitative ratio between these signals determined the outcome of the stimulation with optimal results when anti-4-1BB and anti-CD28 were applied in a 3:1 ratio. Functional CTLs of an effector memory subtype (CD45RA(-) CCR7(-)) were generated in high numbers. We present a highly defined APC platform using off-the-shelf reagents for the convenient generation of large numbers of antigen-specific CTLs.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D011137 Polystyrenes Polymerized forms of styrene used as a biocompatible material, especially in dentistry. They are thermoplastic and are used as insulators, for injection molding and casting, as sheets, plates, rods, rigid forms and beads. Polystyrol,Polystyrene,Polystyrols
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000938 Antigen-Presenting Cells A heterogeneous group of immunocompetent cells that mediate the cellular immune response by processing and presenting antigens to the T-cells. Traditional antigen-presenting cells include MACROPHAGES; DENDRITIC CELLS; LANGERHANS CELLS; and B-LYMPHOCYTES. FOLLICULAR DENDRITIC CELLS are not traditional antigen-presenting cells, but because they hold antigen on their cell surface in the form of IMMUNE COMPLEXES for B-cell recognition they are considered so by some authors. Accessory Cells, Immunologic,Antigen-Presenting Cell,Immunologic Accessory Cells,Accessory Cell, Immunologic,Cell, Immunologic Accessory,Cells, Immunologic Accessory,Immunologic Accessory Cell,Antigen Presenting Cell,Antigen Presenting Cells,Cell, Antigen-Presenting,Cells, Antigen-Presenting
D053261 Tumor Necrosis Factor Receptor Superfamily, Member 9 A member of the tumor necrosis factor receptor superfamily that is specific for 4-1BB LIGAND. It is found in a variety of immune cell types including activated T-LYMPHOCYTES; NATURAL KILLER CELLS; and DENDRITIC CELLS. Activation of the receptor on T-LYMPHOCYTES plays a role in their expansion, production of cytokines and survival. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS. 4-1BB Receptors,Antigens, CD137,CD137 Antigens,4-1BB Receptor,CD137 Antigen,TNFRSF9 Receptor,4 1BB Receptor,4 1BB Receptors,Antigen, CD137,Receptor, 4-1BB,Receptor, TNFRSF9,Receptors, 4-1BB
D017951 Antigen Presentation The process by which antigen is presented to lymphocytes in a form they can recognize. This is performed by antigen presenting cells (APCs). Some antigens require processing before they can be recognized. Antigen processing consists of ingestion and partial digestion of the antigen by the APC, followed by presentation of fragments on the cell surface. (From Rosen et al., Dictionary of Immunology, 1989) Antigen Processing,Antigen Presentations,Antigen Processings
D018106 CD28 Antigens Costimulatory T-LYMPHOCYTE receptors that have specificity for CD80 ANTIGEN and CD86 ANTIGEN. Activation of this receptor results in increased T-cell proliferation, cytokine production and promotion of T-cell survival. Antigens, CD28,CD28 Antigen,T-Cell-Specific Surface Glycoprotein CD28,TP44 Receptor,Antigen, CD28,Receptor, TP44,T Cell Specific Surface Glycoprotein CD28
D018414 CD8-Positive T-Lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-LYMPHOCYTES, CYTOTOXIC) and CD8+ suppressor T-lymphocytes. Suppressor T-Lymphocytes, CD8-Positive,T8 Cells,T8 Lymphocytes,CD8-Positive Lymphocytes,Suppressor T-Cells, CD8-Positive,CD8 Positive Lymphocytes,CD8 Positive T Lymphocytes,CD8-Positive Lymphocyte,CD8-Positive Suppressor T-Cell,CD8-Positive Suppressor T-Cells,CD8-Positive Suppressor T-Lymphocyte,CD8-Positive Suppressor T-Lymphocytes,CD8-Positive T-Lymphocyte,Cell, T8,Cells, T8,Lymphocyte, CD8-Positive,Lymphocyte, T8,Lymphocytes, CD8-Positive,Lymphocytes, T8,Suppressor T Cells, CD8 Positive,Suppressor T Lymphocytes, CD8 Positive,Suppressor T-Cell, CD8-Positive,Suppressor T-Lymphocyte, CD8-Positive,T-Cell, CD8-Positive Suppressor,T-Cells, CD8-Positive Suppressor,T-Lymphocyte, CD8-Positive,T-Lymphocyte, CD8-Positive Suppressor,T-Lymphocytes, CD8-Positive,T-Lymphocytes, CD8-Positive Suppressor,T8 Cell,T8 Lymphocyte

Related Publications

Despina Rudolf, and Tobias Silberzahn, and Steffen Walter, and Dominik Maurer, and Johanna Engelhard, and Dorothee Wernet, and Hans-Jörg Bühring, and Gundram Jung, and Byoung S Kwon, and Hans-Georg Rammensee, and Stefan Stevanović
February 2003, European journal of immunology,
Despina Rudolf, and Tobias Silberzahn, and Steffen Walter, and Dominik Maurer, and Johanna Engelhard, and Dorothee Wernet, and Hans-Jörg Bühring, and Gundram Jung, and Byoung S Kwon, and Hans-Georg Rammensee, and Stefan Stevanović
January 1997, Journal of immunology (Baltimore, Md. : 1950),
Despina Rudolf, and Tobias Silberzahn, and Steffen Walter, and Dominik Maurer, and Johanna Engelhard, and Dorothee Wernet, and Hans-Jörg Bühring, and Gundram Jung, and Byoung S Kwon, and Hans-Georg Rammensee, and Stefan Stevanović
March 2021, European journal of immunology,
Despina Rudolf, and Tobias Silberzahn, and Steffen Walter, and Dominik Maurer, and Johanna Engelhard, and Dorothee Wernet, and Hans-Jörg Bühring, and Gundram Jung, and Byoung S Kwon, and Hans-Georg Rammensee, and Stefan Stevanović
July 2019, Clinical cancer research : an official journal of the American Association for Cancer Research,
Despina Rudolf, and Tobias Silberzahn, and Steffen Walter, and Dominik Maurer, and Johanna Engelhard, and Dorothee Wernet, and Hans-Jörg Bühring, and Gundram Jung, and Byoung S Kwon, and Hans-Georg Rammensee, and Stefan Stevanović
June 1998, The Journal of experimental medicine,
Despina Rudolf, and Tobias Silberzahn, and Steffen Walter, and Dominik Maurer, and Johanna Engelhard, and Dorothee Wernet, and Hans-Jörg Bühring, and Gundram Jung, and Byoung S Kwon, and Hans-Georg Rammensee, and Stefan Stevanović
February 2008, Blood,
Despina Rudolf, and Tobias Silberzahn, and Steffen Walter, and Dominik Maurer, and Johanna Engelhard, and Dorothee Wernet, and Hans-Jörg Bühring, and Gundram Jung, and Byoung S Kwon, and Hans-Georg Rammensee, and Stefan Stevanović
December 2007, Blood,
Despina Rudolf, and Tobias Silberzahn, and Steffen Walter, and Dominik Maurer, and Johanna Engelhard, and Dorothee Wernet, and Hans-Jörg Bühring, and Gundram Jung, and Byoung S Kwon, and Hans-Georg Rammensee, and Stefan Stevanović
February 1997, Journal of immunology (Baltimore, Md. : 1950),
Despina Rudolf, and Tobias Silberzahn, and Steffen Walter, and Dominik Maurer, and Johanna Engelhard, and Dorothee Wernet, and Hans-Jörg Bühring, and Gundram Jung, and Byoung S Kwon, and Hans-Georg Rammensee, and Stefan Stevanović
November 2007, Journal of immunology (Baltimore, Md. : 1950),
Despina Rudolf, and Tobias Silberzahn, and Steffen Walter, and Dominik Maurer, and Johanna Engelhard, and Dorothee Wernet, and Hans-Jörg Bühring, and Gundram Jung, and Byoung S Kwon, and Hans-Georg Rammensee, and Stefan Stevanović
January 2003, Cytokine & growth factor reviews,
Copied contents to your clipboard!